FI893448L - Menetelmä valmistaa terapeuttisesti aktiivinen ranitidiinisuola - Google Patents

Menetelmä valmistaa terapeuttisesti aktiivinen ranitidiinisuola Download PDF

Info

Publication number: FI893448L
Authority: FI; Finland
Prior art keywords: preparing; therapeutically active; ranitidine salt; ranitidine; salt
Prior art date: 1988-07-18

Application number

FI893448A

Other languages

English (en)

Swedish (sv)

Other versions

FI90538C (fi

FI893448A0 (fi

FI90538B (fi

Inventor

John Watson Clitherow

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-07-18

Filing date

1989-07-17

Publication date

1990-01-19

1988-07-18 Priority claimed from GB888817098A external-priority patent/GB8817098D0/en

1989-03-01 Priority claimed from GB898904686A external-priority patent/GB8904686D0/en

1989-07-17 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1989-07-17 Publication of FI893448A0 publication Critical patent/FI893448A0/fi

1990-01-19 Publication of FI893448L publication Critical patent/FI893448L/fi

1993-11-15 Application granted granted Critical

1993-11-15 Publication of FI90538B publication Critical patent/FI90538B/fi

1994-02-25 Publication of FI90538C publication Critical patent/FI90538C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

FI893448A 1988-07-18 1989-07-17 Menetelmä valmistaa terapeuttisesti aktiivinen ranitidiinisuola FI90538C (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB888817098A GB8817098D0 (en)	1988-07-18	1988-07-18	Chemical compounds
GB8817098		1988-07-18
GB8904686		1989-03-01
GB898904686A GB8904686D0 (en)	1989-03-01	1989-03-01	Chemical compounds

Publications (4)

Publication Number	Publication Date
FI893448A0 FI893448A0 (fi)	1989-07-17
FI893448L true FI893448L (fi)	1990-01-19
FI90538B FI90538B (fi)	1993-11-15
FI90538C FI90538C (fi)	1994-02-25

Family

ID=26294175

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI893448A FI90538C (fi)	1988-07-18	1989-07-17	Menetelmä valmistaa terapeuttisesti aktiivinen ranitidiinisuola

Country Status (35)

Country	Link
US (1)	US5008256A (fi)
JP (1)	JP2523185B2 (fi)
KR (1)	KR0122598B1 (fi)
CN (1)	CN1022626C (fi)
AT (1)	AT398200B (fi)
AU (1)	AU632052B2 (fi)
BE (1)	BE1003254A5 (fi)
CA (1)	CA1332610C (fi)
CH (1)	CH679582A5 (fi)
CY (1)	CY1650A (fi)
DE (1)	DE3923638C2 (fi)
DK (1)	DK168381B1 (fi)
EG (1)	EG19368A (fi)
ES (1)	ES2014175A6 (fi)
FI (1)	FI90538C (fi)
FR (1)	FR2634122B1 (fi)
GB (1)	GB2220937B (fi)
GR (1)	GR1000431B (fi)
HK (1)	HK61392A (fi)
HU (2)	HU206104B (fi)
IE (1)	IE61076B1 (fi)
IL (1)	IL91005A (fi)
IT (1)	IT1231481B (fi)
LU (2)	LU88722I2 (fi)
MX (1)	MX174145B (fi)
MY (1)	MY104055A (fi)
NL (2)	NL192604C (fi)
NO (2)	NO176319C (fi)
NZ (1)	NZ229958A (fi)
PL (1)	PL162391B1 (fi)
PT (1)	PT91188B (fi)
SE (1)	SE468715B (fi)
SG (1)	SG51992G (fi)
YU (1)	YU47021B (fi)
ZW (1)	ZW8689A1 (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0282132B1 (en) *	1987-03-09	1992-09-30	The Procter & Gamble Company	Compositions and their use for treating gastrointestinal disorders
IL85472A (en) *	1987-03-09	1991-06-30	Procter & Gamble	Pharmaceutical compositions for treating gastrointestinal disorders
AU641903B2 (en) *	1988-10-26	1993-10-07	Glaxo Group Limited	Carboxylic acid derivatives
GB9004328D0 (en) *	1990-02-27	1990-04-25	Glaxo Group Ltd	Chemical compounds
GB9009240D0 (en) *	1990-04-25	1990-06-20	Glaxo Group Ltd	Chemical compounds
GB9009437D0 (en) *	1990-04-26	1990-06-20	Glaxo Group Ltd	Chemical compounds
US5843482A (en) *	1990-07-20	1998-12-01	Tillotts Pharma Ag	Products and processes for the treatment of the alimentary canal
GB9019875D0 (en) *	1990-09-11	1990-10-24	Glaxo Group Ltd	Pharmaceutical compositions
US5192752A (en) *	1991-01-14	1993-03-09	The Procter & Gamble Company	Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5128140A (en) *	1991-01-14	1992-07-07	The Procter & Gamble Company	Swallowable pharmaceutical compositions
GB9120131D0 (en) *	1991-09-20	1991-11-06	Glaxo Group Ltd	Medicaments
DE69228738D1 (de) *	1991-12-06	1999-04-29	Glaxo Group Ltd	Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
ES2094567T3 (es) *	1992-10-27	1997-01-16	Janssen Pharmaceutica Nv	Derivados de la 4-quinolinilo con actividad anti-helicobacter.
AU1671295A (en) *	1994-12-19	1996-07-10	Lauteral Limited	Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
CA2211873A1 (en) *	1995-01-26	1996-08-01	Michael Droege	Bismuth compounds
GB9501560D0 (en)	1995-01-26	1995-03-15	Nycomed Imaging As	Contrast agents
RU2131264C1 (ru) *	1996-06-04	1999-06-10	Московское производственное химико-фармацевтическое объединение им.Н.А.Семашко	Противоязвенное средство в виде таблеток и способ его получения
EP1035192A1 (de) *	1999-01-26	2000-09-13	Stefan Graichen	Additiv für einen Kühlschmierstoff
CN1102585C (zh) *	1999-04-28	2003-03-05	常州兰陵制药有限公司	雷尼替丁枸橼酸铋盐的制备方法
US20060100271A1 (en) *	2004-11-08	2006-05-11	Keith Whitehead	Stabilized aqueous ranitidine compositions
CN100402514C (zh) *	2006-08-01	2008-07-16	丽珠医药集团股份有限公司	一种制备枸橼酸铋雷尼替丁的方法
CN101484132A (zh) *	2007-07-09	2009-07-15	柏树制药公司	具有合意口味的雷尼替丁制剂
CN102408398B (zh) *	2011-09-20	2012-12-05	江苏汉斯通药业有限公司	枸橼酸铋雷尼替丁的制备方法
US9731999B2 (en)	2011-09-23	2017-08-15	Iqbal Gill	Chemical admixtures for hydraulic cements
ES2426539B1 (es) *	2012-04-18	2014-09-09	Dr Healthcare España, S. L.	Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN103896888B (zh) *	2014-03-28	2015-11-18	常州兰陵制药有限公司	枸橼酸铋雷尼替丁的制备方法
EP2929884A1 (en)	2014-04-11	2015-10-14	Sanovel Ilac Sanayi ve Ticaret A.S.	Pharmaceutical combinations of dabigatran and h2-receptor antagonists
WO2015169957A1 (en)	2014-05-09	2015-11-12	Sanovel Ilac Sanayi Ve Ticaret A.S.	Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists
CN107382921B (zh) *	2017-07-28	2025-04-18	常州兰陵制药有限公司	制备枸橼酸铋雷尼替丁的方法
EP4196793A1 (en)	2020-08-11	2023-06-21	Université de Strasbourg	H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1565966A (en) *	1976-08-04	1980-04-23	Allen & Hanburys Ltd	Aminoalkyl furan derivatives
FR2531706A1 (fr) *	1982-08-13	1984-02-17	Sanofi Sa	Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
BE905235A (fr) *	1986-08-05	1986-12-01	Hasunor Ag	Ascorbates antagonistes des recepteurs h2 et leur procede de preparation.
IT1215325B (it) *	1987-01-07	1990-02-08	Barisintex Sa	Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
IL85472A (en) *	1987-03-09	1991-06-30	Procter & Gamble	Pharmaceutical compositions for treating gastrointestinal disorders
EP0282132B1 (en) *	1987-03-09	1992-09-30	The Procter & Gamble Company	Compositions and their use for treating gastrointestinal disorders
DE3710462A1 (de) *	1987-03-30	1988-10-13	Heumann Pharma Gmbh & Co	Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
GB9004328D0 (en) *	1990-02-27	1990-04-25	Glaxo Group Ltd	Chemical compounds
GB9009437D0 (en) *	1990-04-26	1990-06-20	Glaxo Group Ltd	Chemical compounds

1989
- 1989-07-14 CH CH2647/89A patent/CH679582A5/fr not_active IP Right Cessation
- 1989-07-17 BE BE8900773A patent/BE1003254A5/fr not_active IP Right Cessation
- 1989-07-17 IL IL9100589A patent/IL91005A/en not_active IP Right Cessation
- 1989-07-17 LU LU88722C patent/LU88722I2/fr unknown
- 1989-07-17 EG EG34289A patent/EG19368A/xx active
- 1989-07-17 AT AT0172889A patent/AT398200B/de not_active IP Right Cessation
- 1989-07-17 NZ NZ229958A patent/NZ229958A/xx unknown
- 1989-07-17 GB GB8916288A patent/GB2220937B/en not_active Expired - Lifetime
- 1989-07-17 LU LU87557A patent/LU87557A1/fr active Protection Beyond IP Right Term
- 1989-07-17 YU YU142789A patent/YU47021B/sh unknown
- 1989-07-17 ZW ZW86/89A patent/ZW8689A1/xx unknown
- 1989-07-17 MX MX1682989A patent/MX174145B/es unknown
- 1989-07-17 CN CN89104959A patent/CN1022626C/zh not_active Expired - Fee Related
- 1989-07-17 SE SE8902550A patent/SE468715B/sv not_active IP Right Cessation
- 1989-07-17 ES ES8902517A patent/ES2014175A6/es not_active Expired - Fee Related
- 1989-07-17 MY MYPI89000969A patent/MY104055A/en unknown
- 1989-07-17 IE IE230989A patent/IE61076B1/en not_active IP Right Cessation
- 1989-07-17 DK DK351789A patent/DK168381B1/da not_active IP Right Cessation
- 1989-07-17 DE DE3923638A patent/DE3923638C2/de not_active Expired - Fee Related
- 1989-07-17 JP JP1184402A patent/JP2523185B2/ja not_active Expired - Lifetime
- 1989-07-17 PL PL28062889A patent/PL162391B1/pl unknown
- 1989-07-17 IT IT8948196A patent/IT1231481B/it active Protection Beyond IP Right Term
- 1989-07-17 GR GR890100454A patent/GR1000431B/el not_active IP Right Cessation
- 1989-07-17 NL NL8901840A patent/NL192604C/nl not_active IP Right Cessation
- 1989-07-17 CA CA000605843A patent/CA1332610C/en not_active Expired - Fee Related
- 1989-07-17 FI FI893448A patent/FI90538C/fi not_active IP Right Cessation
- 1989-07-17 NO NO892936A patent/NO176319C/no not_active IP Right Cessation
- 1989-07-17 AU AU38178/89A patent/AU632052B2/en not_active Ceased
- 1989-07-17 PT PT91188A patent/PT91188B/pt not_active IP Right Cessation
- 1989-07-17 FR FR8909575A patent/FR2634122B1/fr not_active Expired - Fee Related
- 1989-07-17 US US07/380,378 patent/US5008256A/en not_active Expired - Lifetime
- 1989-07-17 HU HU893595A patent/HU206104B/hu unknown
- 1989-07-18 KR KR1019890010213A patent/KR0122598B1/ko not_active Expired - Fee Related
1992
- 1992-05-09 SG SG519/92A patent/SG51992G/en unknown
- 1992-08-13 HK HK613/92A patent/HK61392A/xx not_active IP Right Cessation
- 1992-12-11 CY CY1650A patent/CY1650A/en unknown
1995
- 1995-06-12 HU HU95P/P00186P patent/HU211173A9/hu unknown
1997
- 1997-12-18 NL NL970046C patent/NL970046I2/nl unknown
1998
- 1998-02-05 NO NO1998007C patent/NO1998007I1/no unknown

Also Published As

Publication number	Publication date
GR1000431B (el)	1992-07-30
LU87557A1 (fr)	1990-07-24
HK61392A (en)	1992-08-21
YU142789A (en)	1991-04-30
IE892309L (en)	1990-01-18
MX16829A (es)	1993-10-01
ES2014175A6 (es)	1990-06-16
NL970046I1 (nl)	1998-03-02
GR890100454A (en)	1990-06-27
IT8948196A0 (it)	1989-07-17
PT91188B (pt)	1995-03-01
DE3923638C2 (de)	1995-11-23
NZ229958A (en)	1991-09-25
ATA172889A (de)	1994-02-15
NL192604B (nl)	1997-07-01
GB2220937A (en)	1990-01-24
NO176319C (no)	1995-03-15
KR0122598B1 (ko)	1997-11-13
NO892936D0 (no)	1989-07-17
ZW8689A1 (en)	1990-02-21
CY1650A (en)	1992-12-11
CN1039419A (zh)	1990-02-07
HU206104B (en)	1992-08-28
HUT52082A (en)	1990-06-28
JPH02117684A (ja)	1990-05-02
NO892936L (no)	1990-01-19
NL192604C (nl)	1997-11-04
NL8901840A (nl)	1990-02-16
FR2634122B1 (fr)	1993-11-19
CA1332610C (en)	1994-10-18
FI90538C (fi)	1994-02-25
LU88722I2 (fr)	1996-08-23
AU3817889A (en)	1990-01-18
US5008256A (en)	1991-04-16
MY104055A (en)	1993-10-30
JP2523185B2 (ja)	1996-08-07
SG51992G (en)	1992-07-24
PT91188A (pt)	1990-02-08
AU632052B2 (en)	1992-12-17
DK351789D0 (da)	1989-07-17
MX174145B (es)	1994-04-25
CH679582A5 (fi)	1992-03-13
KR910002826A (ko)	1991-02-26
SE8902550D0 (sv)	1989-07-17
SE8902550L (sv)	1990-01-19
GB8916288D0 (en)	1989-08-31
FI893448A0 (fi)	1989-07-17
IE61076B1 (en)	1994-09-21
NO1998007I1 (no)	1998-02-05
IL91005A (en)	1994-10-07
IL91005A0 (en)	1990-02-09
HU211173A9 (en)	1995-11-28
DK351789A (da)	1990-01-19
YU47021B (sh)	1994-11-15
NL970046I2 (nl)	1998-04-01
AT398200B (de)	1994-10-25
FI90538B (fi)	1993-11-15
DE3923638A1 (de)	1990-03-01
IT1231481B (it)	1991-12-07
CN1022626C (zh)	1993-11-03
PL162391B1 (pl)	1993-10-30
GB2220937B (en)	1991-11-27
NO176319B (no)	1994-12-05
SE468715B (sv)	1993-03-08
DK168381B1 (da)	1994-03-21
EG19368A (en)	1995-02-28
FR2634122A1 (fr)	1990-01-19
BE1003254A5 (fr)	1992-02-11

Publication	Publication Date	Title
FI893448L (fi)	1990-01-19	Menetelmä valmistaa terapeuttisesti aktiivinen ranitidiinisuola
FI883050L (fi)	1988-12-25	Menetelmä terapeuttisesti aktiivisten pyranoindolitsinokinoliinijohdannaisten valmistamiseksi
FI890652A7 (fi)	1989-08-11	Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI892497L (fi)	1989-11-25	Menetelmä terapeuttisesti aktiivisten bentsamidijohdannaisten valmistamiseksi
FI870903L (fi)	1987-09-08	Menetelmä terapeuttisesti aktiivisten alfa-heterosykleillä substituoitujen tolunitriilien valmistamiseksi
FI963424L (fi)	1996-09-02	Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
FI860484L (fi)	1986-08-05	Menetelmä terapeuttisesti aktiivisten peptidijohdannaisten valmistamiseksi
FI906204L (fi)	1991-06-23	Menetelmä farmaseuttisesti vaikuttavien peptidiyhdisteiden valmistamiseksi
FI950946A7 (fi)	1995-03-01	Menetelmä terapeuttisesti käyttökelpoisen A83543-yhdisteen valmistamiseksi
FI890282L (fi)	1989-07-21	Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI941523L (fi)	1994-03-31	Menetelmä terapeuttisesti käyttökelpoisen 1-(beta-D-arabinofuranosyyli)-5-propynyyliurasiilin farmaseuttisesti hyväksyttävän emässuolan valmistamiseksi
FI891389L (fi)	1989-09-26	Menetelmä makeutusaineen valmistamiseksi
FI893929L (fi)	1989-08-22	Menetelmä stabiilin sinkki-protamiini- -interferonikompleksin valmistamiseksi
FI894349A7 (fi)	1990-03-16	Menetelmä farmakologisesti aktiivisen nitraattiesterin valmistamiseksi
FI880869A7 (fi)	1988-08-26	Menetelmä terapeuttisesti aktiivisten tetratsolijohdannaisten valmistamiseksi
FI875666L (fi)	1988-06-24	Menetelmä terapeuttisesti aktiivisen kinoliiniyhdisteen valmistamiseksi
FI890283A7 (fi)	1989-07-21	Menetelmä terapeuttisesti käyttökelpoisten 25-hydroksi-vitamiinin D-johdannaisten valmistamiseksi
FI890123L (fi)	1989-07-15	Menetelmä valmistaa terapeuttisesti vaikuttavia indolyylipiperidiiniyhdisteitä
FI922815L (fi)	1992-06-17	Menetelmä uusien farmaseuttisesti aktiivisten D-vitamiinianalogien valmistamiseksi
FI884471A7 (fi)	1989-03-31	Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
FI883300L (fi)	1989-01-15	Menetelmä uusien terapeuttisesti aktiivisten bentsotiofeenien valmistamiseksi
FI924642L (fi)	1992-10-14	Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi
FI884240L (fi)	1989-03-18	Menetelmä paikalliseen käyttöön tarkoitetun farmaseuttisen valmisteen valmistamiseksi
FI884660L (fi)	1989-04-13	Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
FI916058A7 (fi)	1992-06-28	Menetelmä terapeuttisesti aktiivisten dihydrobentsofuraanikarboksamidien valmistamiseksi

Legal Events

Date	Code	Title	Description
1993-10-18	BB	Publication of examined application
2001-08-28	SPCG	Supplementary protection certificate granted	Spc suppl protection certif: L137 Extension date: 20100713
2004-08-31	FG	Patent granted	Owner name: GLAXO GROUP LIMITED
2007-01-31	MA	Patent expired